This article was originally published in The Gray Sheet
200-patient, multisite clinical trial of the Coda posterior lumbar interbody fusion device begins with implantation of first U.S. patient. Coda is the first PLIF system to feature intraoperative adjustment, allowing the surgeon to match the natural curvature of the patient's spine and preventing degenerative disk disease from progressing to other levels of the spine, the firm claims. IDE approval was obtained Feb. 6...
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.